Cyclooxygenase inhibitors derived from thalidomide

Mamiko Suizu, Yohei Muroya, Hiroki Kakuta, Hiroyuki Kagechika, Aya Tanatani, Kazuo Nagasawa, Yuichi Hashimoto

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)


Several N-3,5-dimethylphenylphthalimide analogs possessing more potent cyclooxygenase-inhibiting activity than that of aspirin were prepared during structural development studies based on thalidomide. Substituent effects on the activity were investigated.

Original languageEnglish
Pages (from-to)1098-1102
Number of pages5
JournalChemical and Pharmaceutical Bulletin
Issue number9
Publication statusPublished - Sept 2003
Externally publishedYes


  • Cyclooxygenase
  • Inhibitor
  • Structure-activity relationship
  • Thalidomide

ASJC Scopus subject areas

  • General Chemistry
  • Drug Discovery


Dive into the research topics of 'Cyclooxygenase inhibitors derived from thalidomide'. Together they form a unique fingerprint.

Cite this